Synaptogyrin 1 Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Synaptogyrin 1 Protein</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[SYNGR1](/genes/syngr1)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[O43760](https://www.uniprot.org/uniprotkb/O43760)</td>
</tr>
<tr>
<td class="label">Protein class</td>
<td>Synaptic vesicle tetraspan membrane protein</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Synaptic vesicle membrane</td>
</tr>
<tr>
<td class="label">Primary systems</td>
<td>[Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), striatum, cerebellum</td>
</tr>
<tr>
<td class="label">Major process links</td>
<td>[Synaptic Dysfunction in Neurodegenerative Diseases](/mechanisms/synaptic-dysfunction), [Protein Aggregation and Misfolding in Neurodegeneration](/mechanisms/protein-aggregation)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/bipolar" style="color:#ef9a9a">Bipolar</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">52 edges</a></td>
</tr>
</table>
[Synaptogyrin 1](/proteins/syngr1-protein) is a synaptic-vesicle membrane protein encoded by [SYNGR1](/genes/syngr1). It belongs to the synaptogyrin and synaptophysin tetraspan family and is enriched in presynaptic terminals, where it contributes to vesicle organization and transmitter release control.[@janz1999][@hubler2004] In neurodegeneration research, SYNGR1 is mainly relevant as a marker and potential regulator of presynaptic integrity, a process that fails early in [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis).[@selkoe2002][@kalia2015]
Overview
Synaptogyrin 1 is not a classical catalytic enzyme; instead, it acts as a structural and signaling organizer on synaptic vesicles. It is functionally coupled to presynaptic proteins that set vesicle release probability, including [Synaptophysin Protein](/proteins/synaptophysin), [SNAP-25 Protein](/proteins/snap25-protein), [Syntaxin-1A Protein](/proteins/syntaxin-1a-protein), and [Synaptotagmin-1 Protein](/proteins/synaptotagmin-1-protein), with consequences for [SNARE Complex](/proteins/snare-complex) behavior and short-term synaptic plasticity.[@hubler2004][@sudhof2012]
Structure and Molecular Features
Synaptogyrin 1 is a small hydrophobic membrane protein with four transmembrane helices and short luminal and cytoplasmic loops typical of synaptic vesicle tetraspan proteins.[@janz1999][@hubler2004] This organization supports several key properties:
- High compatibility with curved vesicle membranes.
- Lateral interactions with other vesicle proteins in microdomains.
- Potential regulation by phosphorylation at cytoplasmic residues that tune vesicle-cycle behavior.
Rather than serving as a fusion trigger itself, SYNGR1 appears to set the local membrane context in which core release proteins operate. That makes it mechanistically important in disease states where presynaptic proteostasis and vesicle composition drift over time.[@selkoe2002][@sudhof2012]
Function in Healthy Nervous System
Vesicle pool organization
Experimental work on synaptic vesicle proteins suggests that synaptogyrin-family members influence vesicle pool partitioning and the ratio of readily releasable versus reserve vesicles.[@hubler2004][@sudhof2012] In circuit terms, this affects reliability during repetitive firing.
Release probability and short-term plasticity
SYNGR1 is linked to modulation of release probability and short-term depression or facilitation under sustained activity. These effects are especially relevant in high-frequency pathways where small changes in vesicle priming propagate into network-level changes in oscillation and synchrony.[@sudhof2012][@jackman2017]
Presynaptic resilience
By helping preserve vesicle composition and trafficking efficiency, SYNGR1 contributes to presynaptic resilience under metabolic and oxidative stress, both of which are central in aging brain tissue.[@selkoe2002][@jackman2017]
Role in Neurodegeneration
Alzheimer's disease
Synapse loss tracks cognitive decline more tightly than plaque burden, and presynaptic proteins are often reduced or mislocalized in affected cortex and hippocampus.[@selkoe2002][@kalia2015] SYNGR1 is therefore best interpreted as part of a vulnerable presynaptic module that fails early during [Alzheimer's Disease](/diseases/alzheimers-disease), particularly in pathways supporting memory encoding and retrieval.
Parkinson's disease
Nigrostriatal degeneration includes widespread presynaptic remodeling. In [Parkinson's Disease](/diseases/parkinsons-disease), proteins that regulate vesicle cycling are perturbed alongside [Alpha-Synuclein Aggregation Pathway in Parkinson's Disease](/mechanisms/alpha-synuclein-aggregation-pathway), suggesting a plausible mechanistic bridge between aggregation stress and neurotransmitter release failure.[@kalia2015][@bridi2018]
ALS and ALS-FTD spectrum
In [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) and [ALS-FTD Spectrum](/diseases/als-ftd-spectrum), early cortical and spinal synaptic dysfunction precedes major cell loss. SYNGR1 belongs to the protein set likely impacted by impaired RNA metabolism and axonal transport, yielding cumulative presynaptic failure.[@fogarty2019][@sleigh2014]
Biomarker and Translational Relevance
SYNGR1 is not yet a frontline clinical biomarker, but it is useful in research panels that quantify synapse-associated proteins in tissue, CSF-derived extracellular vesicles, and multi-omic datasets. Its value is highest when interpreted with other presynaptic and postsynaptic markers rather than alone.[@selkoe2002][@jackman2017]
Therapeutically, SYNGR1 itself is not currently a direct drug target. Instead, it is a mechanistic readout for interventions aimed at:
- improving synaptic vesicle cycling,
- reducing proteotoxic stress,
- stabilizing presynaptic mitochondrial function, and
- rescuing circuit-level neurotransmission in early disease windows.
See Also
- [SYNGR1 Gene](/genes/syngr1)
- [Synaptophysin Protein](/proteins/synaptophysin)
- [SNAP-25 Protein](/proteins/snap25-protein)
- [Syntaxin-1A Protein](/proteins/syntaxin-1a-protein)
- [SNARE Complex](/proteins/snare-complex)
- [Synaptic Dysfunction in Neurodegenerative Diseases](/mechanisms/synaptic-dysfunction)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
Background
The study of Synaptogyrin 1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Janz R, Soderberg C, Sudhof TC, Synaptogyrins form a conserved family of synaptic vesicle membrane proteins (1999)](https://pubmed.ncbi.nlm.nih.gov/10622412/)
[Hubler D, Rankovic M, Richter K, et al, Synaptogyrin and synaptophysin in synaptic vesicle function (2004)](https://pubmed.ncbi.nlm.nih.gov/15126693/)
[Selkoe DJ, Alzheimer disease is a synaptic failure (2002)](https://pubmed.ncbi.nlm.nih.gov/11689949/)
[Kalia LV, Lang AE, Parkinson disease in 2015 evolving basic pathogenic concepts (2015)](https://pubmed.ncbi.nlm.nih.gov/26667666/)
[Sudhof TC, The presynaptic active zone (2012)](https://pubmed.ncbi.nlm.nih.gov/22462542/)
[Jackman SL, Regehr WG, The mechanisms and functions of synaptic facilitation (2017)](https://pubmed.ncbi.nlm.nih.gov/27780033/)
[Bridi JC, Hirth F, Mechanisms of alpha-synuclein induced synaptopathy in Parkinson disease (2018)](https://pubmed.ncbi.nlm.nih.gov/30744573/)
[Fogarty MJ, Driven to decay synaptic dysfunction in amyotrophic lateral sclerosis (2019)](https://pubmed.ncbi.nlm.nih.gov/31292318/)
[Sleigh JN, Rossor AM, Fellows AD, et al, Axonal transport and neurological disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24709998/)